DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Treatment of Polytraumatisms With Corticoids

Information source: Nantes University Hospital
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Polytraumatism

Intervention: hydrocortisone (Drug); NaCl (Drug)

Phase: Phase 2/Phase 3

Status: Recruiting

Sponsored by: Nantes University Hospital

Official(s) and/or principal investigator(s):
Mahe Joachim, MD, Principal Investigator, Affiliation: CHU de Nantes

Overall contact:
Mahe joachim, MD, Phone: 02 40 08 41 54, Email: joachim.mahe@chu-nantes.fr

Summary

Interest of treatment of polytraumatisms with corticoids (hydrocortisone) for patient with relative adrenocortical insufficiency on frequency of nosocomial infection, and hemodynamic complications and organs injuries.

Clinical Details

Official title: Interest of Treatment of Polytraumatisms With Corticoids (Hydrocortisone) for Patient With Relative Adrenocortical Insufficiency

Study design: Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study

Primary outcome: Incidence of nosocomial pneumopathy: radiological, clinical and bacteriological criteria

Secondary outcome: Incidence of pulmonar infection, bacteremia, urinary infections, infections of the operatory sites, incidence of SDRA, organ dysfunction,mortality, etc.

Eligibility

Minimum age: 15 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age superior of 15 years

- Hospitalization inréanimation for polytraumatism (lesion of two organs with a vital

risk)

- SISS score more than 15

- Intubation for more than 48 hours.

- Agreement of a family member

- Patient with insurance

Exclusion Criteria:

- History of corticothérapie within 6 months

- History of adrenocortical insufficiency.

- Treatment by immunosuppressor

- Immunodeficiency.

Locations and Contacts

Mahe joachim, MD, Phone: 02 40 08 41 54, Email: joachim.mahe@chu-nantes.fr

CHU Morvan de Brest, Brest 29609, France; Not yet recruiting
ARVIEUX, Charles, MD
ARVIEUX Charles, MD, Principal Investigator

CHU Pontchaillou, Rennes 35033, France; Not yet recruiting
MALLEDANT yannick, Md
MALLEDANT yannick, MD, Principal Investigator

CHU Trousseau, Tours 37044, France; Not yet recruiting
FUSCIARDI jacques, MD
FUSCIARDI jacques, MD, Principal Investigator

Hôtel Dieu, Nantes 44093, France; Recruiting
Roquilly Antoine, CCA
Mahe Joachim, Md, Principal Investigator
Asehnoune Karim, MD, Sub-Investigator

CHU Bordeaux, Bordeaux, France; Recruiting
Laurent MERSON, PH
Laurent MERSON, PH, Principal Investigator
Françoise MASSON, PH, Sub-Investigator

CH La Roche Sur Yon, La Roche Sur Yon, France; Recruiting
Benoît RENARD, PH
Benoît RENARD, PH, Principal Investigator

CHU Caen, Caen, France; Recruiting
S. ALLOUCHE, PH
S. ALLOUCHE, PH, Principal Investigator

Additional Information

Starting date: November 2006
Ending date: November 2008
Last updated: October 17, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009